Dr. Reddy’s Laboratories, pharmaceutical company, launched esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg, a therapeutic equivalent generic version of AstraZeneca Ab Corporation's Nexium (esomeprazole magnesium) delayed-release capsules in the US market on September 25, 2015, following the approval by the United States Food & Drug Administration (US FDA). Dr. Reddy’s esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg are available in bottle count size of 30.
Subscribe to PharmaTutor News Alerts by Email >>
